ConvaTec Group PLC (LON:CTEC) Insider Christopher Gent Purchases 38,889 Shares

ConvaTec Group PLC (LON:CTEC) insider Christopher Gent acquired 38,889 shares of the firm’s stock in a transaction dated Wednesday, October 18th. The stock was bought at an average price of GBX 213 ($2.81) per share, for a total transaction of £82,833.57 ($109,307.96).

ConvaTec Group PLC (LON CTEC) opened at 199.60 on Friday. ConvaTec Group PLC has a 12-month low of GBX 191.20 and a 12-month high of GBX 349.10. The firm’s 50-day moving average is GBX 256.08 and its 200 day moving average is GBX 291.90. The stock’s market capitalization is GBX 3.90 billion.

The company also recently announced a dividend, which was paid on Friday, October 20th. Investors of record on Thursday, September 7th were given a GBX 1.06 ($0.01) dividend. This represents a yield of 0.36%. The ex-dividend date was Thursday, September 7th.

COPYRIGHT VIOLATION NOTICE: This piece of content was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2017/10/28/christopher-gent-buys-38889-shares-of-convatec-group-plc-ctec-stock.html.

A number of research analysts recently commented on CTEC shares. Numis Securities Ltd reduced their target price on shares of ConvaTec Group PLC from GBX 260 ($3.43) to GBX 250 ($3.30) and set a “reduce” rating for the company in a research note on Wednesday, August 9th. Peel Hunt restated a “buy” rating and issued a GBX 380 ($5.01) target price on shares of ConvaTec Group PLC in a research note on Thursday, August 3rd. Credit Suisse Group reduced their target price on shares of ConvaTec Group PLC from GBX 280 ($3.69) to GBX 225 ($2.97) and set a “neutral” rating for the company in a research note on Tuesday, October 17th. Deutsche Bank AG restated a “buy” rating and issued a GBX 330 ($4.35) target price on shares of ConvaTec Group PLC in a research note on Sunday, August 6th. Finally, Citigroup Inc. restated a “neutral” rating and issued a GBX 290 ($3.83) target price on shares of ConvaTec Group PLC in a research note on Wednesday, October 11th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and a consensus price target of GBX 266.70 ($3.52).

About ConvaTec Group PLC

ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.

Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply